PTEN is mutated in 25–60% of GBM tumors [4], [5] and constitutive activation of the PI3K/AKT pathway, due to PTEN mutation, is associated with increased proliferation rate, invasion, metastasis and poor prognosis [6]–[8]. The gene discussed is AKT1; the disease is glioblastoma.